InvestorsHub Logo
Followers 1
Posts 106
Boards Moderated 0
Alias Born 04/08/2017

Re: None

Sunday, 04/30/2017 11:44:36 PM

Sunday, April 30, 2017 11:44:36 PM

Post# of 369
MRLA: Merck partnership news pending.

MRK received approval for the first immuno-therapy for skin cancer recently.

Now they will move ahead with the MRLA partnership on the diagnostic end.

That news likely sends MRLA over $5.00 a share.

Best of luck to the smart folks that own MRLA now.

Link:
https://www.ft.com/content/cbc629a6-1086-11e7-b030-768954394623
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBIX News